Ptc Therapeutics (PTCT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to -$1.7 billion.
- Ptc Therapeutics' Enterprise Value fell 6655.7% to -$1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 billion, marking a year-over-year decrease of 6655.7%. This contributed to the annual value of -$1.1 billion for FY2024, which is 2999.26% down from last year.
- Latest data reveals that Ptc Therapeutics reported Enterprise Value of -$1.7 billion as of Q3 2025, which was down 6655.7% from -$2.0 billion recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Enterprise Value ranged from a high of -$286.3 million in Q1 2023 and a low of -$2.0 billion during Q1 2025
- Moreover, its 5-year median value for Enterprise Value was -$876.7 million (2023), whereas its average is -$894.8 million.
- In the last 5 years, Ptc Therapeutics' Enterprise Value surged by 6676.83% in 2022 and then plummeted by 24373.22% in 2024.
- Ptc Therapeutics' Enterprise Value (Quarter) stood at -$773.4 million in 2021, then skyrocketed by 46.89% to -$410.7 million in 2022, then crashed by 113.47% to -$876.7 million in 2023, then decreased by 29.99% to -$1.1 billion in 2024, then crashed by 48.09% to -$1.7 billion in 2025.
- Its Enterprise Value was -$1.7 billion in Q3 2025, compared to -$2.0 billion in Q2 2025 and -$2.0 billion in Q1 2025.